Venture Capital

Jotit: Education Technology Company Raises $10 Million (Seed)

By Amit Chowdhry ● Jan 14, 2025

Jotit, a platform designed to simplify and streamline learning in the digital age, announced the closing of its $10 million seed funding round led by Owl Ventures. Other key investors include Good Company VC, Cresson Management, Two Lanterns VC, One Line VC, Paul Volosov, Guy Gamzu, Amit Gilon, and MindCET Capital.

Verastem Oncology: $150 Million Credit Facility Deal Signed

By Amit Chowdhry ● Jan 14, 2025

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, announced a new credit facility for up to $150 million and an equity investment of $7.5 million with Oberland Capital Management.

Aerin Medical: $32.5 Million Raised To Advance Growth

By Amit Chowdhry ● Jan 14, 2025

Aerin Medical - a high-growth medical device company focused on expanding access to meaningful relief for millions of patients suffering from chronic ENT conditions - announced the completion of two significant financial transactions.

Pipe17: AI-Based Order Operations Solutions Company Raises $15.5 Million (Series A)

By Amit Chowdhry ● Jan 14, 2025

Pipe17, a leading provider of AI-based composable order operations, announced a $15.5 million funding round, highlighting the company's rapid growth and strategic vision to transform commerce operations. And the company recently hired its first Chief Operating Officer, Kelly Goetsch, a recognized industry pioneer who joined Pipe17 from commercetools, where he helped scale the company to over $100 million in annual recurring revenue (ARR).

Float Financial: C$70 Million (Series B) Raised For Building Business Solutions

By Amit Chowdhry ● Jan 13, 2025

Float Financial, a business finance platform for Canadian businesses, has signed a C$70 million Series B financing round, bringing its total funds raised in the last year to $120 million. The funding round was led by Growth Equity at Goldman Sachs Alternatives, with participation from OMERS Ventures, FJ Labs, Teralys, and existing investor Garage Capital.

hc1: $6.25 Million Raised To Transform Lab Data Into Actionable Intelligence

By Amit Chowdhry ● Jan 13, 2025

hc1, a leader in transforming lab data into actionable intelligence that improves patient health outcomes while boosting the bottom line, announced it raised $6.25 million in new financing after a successful acquisition in October 2024 of Accumen. Existing investor Health Cloud Capital led the investment with participation from health tech investment firm A1 Health Ventures. And Arsenal Capital Partners joined the investor base in the combined platform via its ownership stake in Accumen.

ThreatMark: $23 Million Raised To Fight Online Fraud

By Amit Chowdhry ● Jan 13, 2025

ThreatMark, a leading innovator in behavior-based fraud prevention, announced it has closed a $23 million funding round. The funding round includes $15 million from Octopus Ventures and Riverside Acceleration Capital (RAC), a US-based growth capital partner to B2B software companies, and an $8 million convertible note from Springtide Ventures Fund.

Raspberry AI: Fashion-Focused GenAI Company Raises $24 Million (Series A)

By Amit Chowdhry ● Jan 13, 2025

Raspberry AI, a leading generative AI platform for fashion creatives, announced it secured $24 million in Series A funding led by Andreessen Horowitz (a16z). Existing investors Greycroft, Correlation Ventures, and MVP Ventures participated in the round, along with notable angel investors such as Gokul Rajaram and Ken Pilot.

BBT.live: Secure Connectivity Company Raises $11.5 Million (Seed)

By Amit Chowdhry ● Jan 13, 2025

BBT.live, an innovator in secure connectivity over public infrastructure, announced the expansion of its seed funding round to $11.5 million, driven by an additional $2 million investment. Accel Solutions Group led the funding round.

Kerna Labs: Seed Funding Raised To Develop Novel RNA-Based Medicines

By Amit Chowdhry ● Jan 13, 2025

Kerna Laboratories - a San Francisco-based AI biotech startup - announced it emerged from stealth with the launch of an AI platform for developing novel RNA-based medicines. Kerna Labs has recently closed an oversubscribed seed funding round, with investors including Gradient, Humba Ventures, Tau Ventures, Pioneer Fund, Focalpoint Partners, and prominent angels including Patrick Hsu (Arc Institute) and Jacob Kimmel (NewLimit).

First Ascent Biomedical: $6 Million Raised For Personalized Cancer Treatments

By Amit Chowdhry ● Jan 13, 2025

First Ascent Biomedical, a pioneer in personalized cancer treatment, announced a $6 million investment from Vidal Duart Enterprises, with an additional co-investment from Techstars. And the funding round will accelerate First Ascent Biomedical’s mission to transform medical oncology with highly individualized, prospective treatment planning technologies that improve patient survival.

Fermata: $10 Million (Series A) Raised For Computer Vision Agriculture Solutions

By Amit Chowdhry ● Jan 13, 2025

Fermata, a data science company specializing in computer vision agriculture solutions, announced it closed $10 million in a Series A funding round backed by Raw Ventures. This funding will support the company's vision of developing a centralized digital brain for the horticulture industry, enabling autonomous management of crops through advanced data analysis and creating a system that continuously learns from available data.

Caidya: Clinical Research Organization Raises $165 Million

By Amit Chowdhry ● Jan 13, 2025

Caidya, a leading global mid-sized clinical research organization (CRO), announced the closing of a strategic growth investment of $165 million from funds managed by Rubicon Founders, a U.S.-based healthcare investment firm focused on building transformational companies.

Windward Bio: Drug Development Company Raises $200 Million (Series A)

By Amit Chowdhry ● Jan 13, 2025

Novo Holdings, a leading life science investor, announced that it has invested in a $200 million Series A launch financing for Windward Bio. This oversubscribed Series A launch financing was co-led by OrbiMed, Novo Holdings and Blue Owl Healthcare Opportunities, and joined by SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital, and Pivotal bioVenture Partners.

RAAPID: Series A Funding Raised From Microsoft’s M12

By Amit Chowdhry ● Jan 13, 2025

Healthcare AI company RAAPID announced a significant Series A investment from M12, which is Microsoft's venture fund. And this strategic funding positions RAAPID to expand its groundbreaking Neuro-symbolic AI platform that reshapes healthcare risk adjustment.

Alphi Capital: Inaugural Fund Closed At C$295 Million

By Amit Chowdhry ● Jan 13, 2025

Alphi Capital - a lower middle-market private equity firm focused on partnering with service-based companies in Canada - announced the final closing of its debut fund, Alphi Capital I, LP with total limited partner commitments of C$295 million. This fund had strong interest from investors and significantly exceeded its C$200 million target.

Recognize Announces Majority Investment in Sprout

By Amit Chowdhry ● Jan 13, 2025

Recognize - a private equity firm focused on investing in digital services businesses - announced that it has made a majority investment in IT asset disposition (ITAD) provider Sprout. And New Capital Partners, an investor in Sprout since 2019, will continue as a minority investor.

Palm Beach Capital: Strategic Investment In MBI Companies

By Amit Chowdhry ● Jan 13, 2025

Palm Beach Capital Fund VI - through one of its investment entities - announced that it has made a strategic investment in MBI Companies, a leading architecture and engineering design firm based in Knoxville, Tennessee.

Timberlyne: $180 Million (Series A) Raised To Develop Novel Therapies For Autoimmune Disorders

By Amit Chowdhry ● Jan 13, 2025

Timberlyne Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders, announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in-class monoclonal antibody targeting CD38, for diseases of high unmet medical needs. The funding was led by investors Abingworth, Bain Capital Life Sciences, and Venrock Healthcare Capital Partners, with participation from Boyu Capital, Lilly Asia Ventures, Braidwell LP, and 3H Health Investment.

Swift Ventures: Interview With General Partner Brett Wilson About The AI-Focused Firm Of Founders Backing Founders

By Amit Chowdhry ● Jan 13, 2025

Swift Ventures is a venture capital firm with roots in Berkeley, California that primarily invests in early-stage AI startups. Investments by Swift include Arize AI, Dash Bio, GrayMatter Robotics, Superhuman, SafelyYou, Tubi (acquired), and others. Started by the founders of TubeMogul – which was acquired by Adobe in 2016 – Swift touts “garage-to-IPO building and scaling expertise.” Pulse 2.0 interviewed Swift Ventures general partner Brett Wilson to learn more about the firm after its recent launch of a new AI Index.

nsave: $18 Million (Series A) Raised For Launching Investment Platform

By Amit Chowdhry ● Jan 13, 2025

nsave, a provider of compliant accounts abroad to people from countries with high inflation, announced launching an investment product, enabling people at risk of financial exclusion to protect and grow their wealth. The company also confirmed an $18 million Series A funding led by TQ Ventures with participation from Sequoia Capital, Y Combinator, ACE Ventures, and Proton Foundation to drive their growth.

RhyGaze: $86 Million (Series A) Raised To Develop Gene Therapies For Retinal Diseases

By Amit Chowdhry ● Jan 13, 2025

RhyGaze, a biotechnology company based in Basel, Switzerland, and Philadelphia, PA, announced that it has raised a Series A funding round of $86 million. The funding round was led by GV (Google Ventures), alongside Arch Venture Partners, F-Prime Capital, and founding investors BioGeneration Ventures and Novartis Venture Fund, who contributed $11 million to an earlier seed round.

Kardigan: $300 Million Raised For Modernizing Cardiovascular Drug Development

By Amit Chowdhry ● Jan 13, 2025

Kardigan - a heart health company modernizing cardiovascular drug development - announced it launched with a mission to develop multiple targeted treatments in parallel, bringing people with cardiovascular diseases closer to the cures they deserve. The company also recently closed a $300 million Series A financing led by Perceptive Advisors, ARCH Venture Partners, and Sequoia Heritage.

Andreessen Horowitz Partnering With Lilly On $500 Million Biotech Ecosystem Venture Fund

By Amit Chowdhry ● Jan 13, 2025

Andreessen Horowitz (a16z) Bio + Health announced a newly formed and first-of-its-kind venture capital fund to fuel broader innovation in human health in partnership with Eli Lilly and Company (Lilly). The Biotech Ecosystem Venture Fund aims to drive transformative progress in healthcare by investing in therapeutic platforms and technology companies that can bring new medicines and disease treatments to improve patients’ lives.

Saluda Medical: $100 Million Of Financing Closed

By Amit Chowdhry ● Jan 13, 2025

Saluda Medical - a commercial-stage medical device company focused on developing treatments for chronic neurological conditions utilizing a novel closed-loop and dose-control neuromodulation platform - announced the closing of a $100 million financing.

Normunity: $75 Million (Series B) Raised For Broadening Pipeline Of Novel Anti-Cancer Therapies

By Amit Chowdhry ● Jan 13, 2025

Normunity, a biotechnology company creating novel anti-cancer therapies, announced today that it closed a Series B funding round of $75 million. The funding was co-led by Samsara BioCapital and Enavate Sciences, alongside other new investors Regeneron Ventures, Pfizer Ventures and YK Bioventures, as well as existing investors Canaan Partners, Sanofi Ventures, Taiho Ventures, Osage Venture Partners, HongShan Capital Group, and Connecticut Innovations. And the Board of Directors will be expanded to include David Parry, PhD (Samsara), Sara Nayeem, MD (Enavate), and Marie-Clare Peakman, MD (Pfizer Ventures).

Tidal Cyber Buying Zero-Shot Security

By Amit Chowdhry ● Jan 13, 2025

Tidal Cyber, the Threat-Informed Defense company, announced the acquisition of Zero-Shot Security, the creator of an innovative artificial intelligence (AI) solution that simplifies and speeds the processing and analysis of threat intelligence.

R4 Capital: $10.6 Billion Surpassed In 2024

By Amit Chowdhry ● Jan 13, 2025

R4 Capital, a national affordable housing tax-credit syndicator, lender, and asset manager, and R4 Capital Funding (R4CF), R4's tax-exempt lending platform, announced in 2024 that it surpassed $10.6 billion in equity and mortgage financing since being founded. This was a significant year, marking the most equity closed in a single year, the largest mortgage loan volume closed in a single quarter, and the most important single asset equity investment in the company's history.

IQHQ: $900 Million Raised In 2024

By Amit Chowdhry ● Jan 13, 2025

IQHQ - a premier owner and developer of life science districts - announced that $900 million of new capital was raised in 2024, with the most recent closing occurring in December 2024.

Holly: AI-Based Government Hiring Platform Raises $2.2 Million

By Amit Chowdhry ● Jan 13, 2025

Holly, an AI-based platform modernizing government hiring, announced the closing of its $2.2 million oversubscribed pre-seed round, led by J2 Ventures with participation from Roble Ventures, Gaingels, and notable angel investors. And the funding will support Holly's platform as it works to solve the million-job government workforce vacancy crisis.